Viewing Study NCT02013128


Ignite Creation Date: 2025-12-26 @ 11:14 AM
Ignite Modification Date: 2026-02-21 @ 9:03 AM
Study NCT ID: NCT02013128
Status: COMPLETED
Last Update Posted: 2022-10-24
First Post: 2013-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ublituximab + Ibrutinib in Select B-cell Malignancies
Sponsor: TG Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module